Note B - The Southern California Regional Gamma Knife Center (Tables)

6 Months Ended

Jun. 30, 2024

NeuroPartners LLC and Corona Gamma Knife, LLC (“CGK”) [Member]

Notes Tables

Equity Method Investments [Table Text Block]

	Six Months Ended
	June 30,
	2024		2023
Patient revenue	$	-	$	136,000
Net loss	$	-	$	(75,000	)
USNC's equity in (loss) earnings of NeuroPartners LLC and CGK	$	-	$	(63,000	)

	June 30,		December 31,
	2024		2023
Current assets	$	-	$	363,000
Noncurrent assets		-		-
Total assets	$	-	$	363,000
Current liabilities	$	-	$	653,000
Noncurrent liabilities		-		-
Equity		-		(290,000	)
Total liabilities and equity	$	-	$	363,000